SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBUMP.L Regulatory News (BUMP)

  • There is currently no data for BUMP

Capital Reduction

9 Nov 2022 07:00

RNS Number : 7381F
Seraphine Group PLC
09 November 2022
 

09 November 2022

 

Seraphine Group plc

('Seraphine' or 'the Group' or 'the Company')

Capital Reduction Effective

 

Seraphine(LON:BUMP), an international digitally-led maternity and nursing wear brand, is pleased to announce that following the passing of a special resolution of the Company at its annual general meeting on 21 September 2022, the High Court of Justice in England and Wales formally approved the reduction of the Company's share premium account (the "Capital Reduction") at a hearing held on 25 October 2022. The Court order confirming the Capital Reduction and a statement of capital approved by the Court were registered with the Registrar of Companies on 8 November 2022 and accordingly the Capital Reduction is now effective.

The Capital Reduction creates additional distributable reserves to the value of £40,000,000, which is intended to support the payment of future dividends to shareholders, with any payment being subject always to the financial performance of the Company and relevant law. The Company does not intend to change its dividend policy following the Capital Reduction and the creation of distributable reserves.

 

The Capital Reduction did not change the number of the Company's ordinary shares in issue or their nominal value of £0.01 each.

 

For further information please contact:

Seraphine Group plc:

David Williams (CEO) via Buchanan Communications

Lee Williams (CFO) via Buchanan Communications

Bridget Green (Company Secretary) via Buchanan Communications

Buchanan Communications

General: seraphine@buchanan.uk.com or (0)20 7466 5000

Helen Tarbet

Simon Compton

 

Notes for editors

About Seraphine

Seraphine is an international digitally-led maternity and nursing wear brand with a diverse range of innovative maternity and nursing products serving an under-competed global market.

Seraphine was founded in 2002 with the vision of creating desirable clothes which women would want to wear even if they were not pregnant, and this ethos remains true to this day. The Group has over 18 years' experience designing and developing maternity and nursing wear for women from first trimester to post-partum and nursing products.

The Group has achieved global brand recognition through its rapidly growing digital platform, which in the year to 4 April 2021, contributed to approximately 89% of revenue. The Group currently exports products to customers in over 120 countries globally, with the Group's largest markets being Europe, North America and the UK.

Seraphine is listed on the Main Market of the London Stock Exchange.

For more information, please visit our website at https://www.seraphinegroupplc.com/

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CARBRBDBLBGDGDI
12
Date   Source Headline
28th Jul 20227:00 amRNSNotice of Results
14th Jul 202211:19 amRNSNotification of Major Holdings
25th May 20225:03 pmRNSNotification of Major Holdings
24th May 20225:26 pmRNSNotification of Major Holdings
13th May 202210:03 amRNSNotification of Major Holdings
5th May 20227:00 amRNSYear End Trading Update
24th Mar 20224:23 pmRNSHolding(s) in Company
24th Mar 20224:21 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSTrading Update
6th Jan 20223:08 pmRNSHolding(s) in Company
22nd Dec 20217:00 amRNSCFO Appointment
14th Dec 20217:00 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSInterim Results
25th Nov 20214:46 pmRNSHolding(s) in Company
14th Oct 20217:00 amRNSCORRECTION Director/PDMR Shareholding
14th Oct 20217:00 amRNSCORRECTION Director/PDMR Shareholding
23rd Sep 20211:36 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:23 pmRNSDirector/PDMR Shareholding
23rd Sep 20217:00 amRNSTrading Statement
20th Aug 202112:50 pmRNSHolding(s) in Company - TR1 Notification
21st Jul 20217:00 amRNSHolding(s) in Company
19th Jul 20215:34 pmRNSHolding(s) in Company
19th Jul 20215:30 pmRNSHolding(s) in Company - TR1 Notification
19th Jul 20215:29 pmRNSHolding(s) in Company - TR1 Notification
19th Jul 20212:10 pmRNSHolding(s) in Company
19th Jul 20217:00 amRNSDirector/PDMR Shareholding - Grant of LTIP Awards
16th Jul 20217:00 amRNSAdmission to Trading on the London Stock Exchange
13th Jul 20211:28 pmRNSApproval and Publication of Prospectus
13th Jul 20217:00 amRNSAnnouncement of Offer Price
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.